We Can Medicines Revenue

We Can Medicines had revenue of 797.87M TWD in the quarter ending March 31, 2025, a decrease of -2.47%. This brings the company's revenue in the last twelve months to 3.25B, up 2.51% year-over-year. In the year 2024, We Can Medicines had annual revenue of 3.27B with 4.69% growth.

Revenue (ttm)

3.25B

Revenue Growth

+2.51%

P/S Ratio

0.48

Revenue / Employee

3.23M

Employees

1,005

Market Cap

1.55B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.27B	146.31M	4.69%
Dec 31, 2023	3.12B	-179.84M	-5.45%
Dec 31, 2022	3.30B	508.66M	18.21%
Dec 31, 2021	2.79B	127.32M	4.77%
Dec 31, 2020	2.67B	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Uni-President Enterprises	668.15B
President Chain Store	341.50B
Great Wall Enterprise	102.97B
Lian Hwa Foods	12.42B
Charoen Pokphand Enterprise (Taiwan)	27.74B
Standard Foods	28.97B
TTET Union	21.84B
Hey Song	9.84B

Revenue Rankings